Definitive Contract HT942525CE052
Award Date 9/26/25
Potential Completion Date 1/25/28
Potential Value $1.3M
Federal Agency
Awardee
Ultimate Awardee
Not listed NAICS Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
Total Small Business
Extent Competed
Full and Open Competition after exclusion of sources
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Lowell, MA 01852, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
1
Legislative Mandate
Employment Eligibility Verification
National Interest Action
Not listed Research Type
SBIR Program Phase II Action
Primary Consortia Member
Not listed Similar Awards
- The Defense Health Agency has awarded a $249,969 Small Business Innovation Research (SBIR) Phase I contract to Emergingdx Inc., a Lowell, Massachusetts-based diagnostic technology company, for the development of an integrated multiplexed low-cost diagnostic platform for rapid microbial identification. This total small business set-aside contract, designated as a purchase order with firm fixed price terms, represents the initial phase of research and development aimed at advancing medical...
- This is a Small Business Innovation Research (SBIR) Phase II contract awarded by the Defense Health Agency (DHA) to Emergingdx Inc., a small business based in Mansfield, Massachusetts. The contract, valued at $1,299,988.98, supports the development of an automated detection platform for circulating and exosomal microRNAs. This research and development effort is focused on medical diagnostics and aligns with the DHA's mission to advance healthcare technologies. The contract was awarded on...
- The U.S. Defense Health Agency (DHA) awarded a Small Business Technology Transfer (STTR) Phase II contract to Emergingdx Inc., a small business subchapter S corporation based in Lowell, Massachusetts. The $1,299,985.23 Firm Fixed Price contract, which is set aside for total small business, supports the development of a "Multiplexed Diagnostic Platform for Invasive Fungal Infection." This contract builds upon earlier SBIR Phase I exploratory research and aims to advance innovative...
- This is a Small Business Innovation Research (SBIR) Phase I contract awarded by the Defense Health Agency (DHA) to Emergingdx Inc., a for-profit subchapter S corporation based in Mansfield, Massachusetts. The $249,998.68 firm-fixed-price contract is for the development of a "Multiplexed Diagnostic Platform for Invasive Fungal Infection." Emergingdx is a company focused on developing diagnostic and biosensor technologies, with an emphasis on disease detection and precision medicine...
- This is a firm fixed price SBIR Phase I contract awarded by the Department of the Navy Secretary of the Navy Office of Naval Research to Emergingdx Inc., a for-profit subchapter S corporation. The $239,636.00 contract funds research under the SBIR Program to advance disease detection and precision medicine capabilities. Emergingdx Inc. has also received several other recent SBIR and STTR Phase I awards from the Defense Health Agency and Department of Agriculture to develop biosensors, microRNA...
- The U.S. Air Force Research Laboratory (AFRL) awarded a $1.25 million SBIR Phase II contract to Dxlab Inc., a small business based in Somerville, Massachusetts, on June 7, 2024. Under this firm fixed-price purchase order, Dxlab will develop a portable and rugged infection diagnostic platform designed to deliver rapid, clinically actionable pathogen detection capabilities at deployed military locations and treatment facilities. The contract is designated as a Total Small Business set aside and...
- This is a Small Business Innovation Research (SBIR) Phase II contract awarded by the Department of the Army Materiel Command to Dxdiscovery Inc., a for-profit Subchapter S corporation, to conduct research and development efforts. The total award amount is $999,995.10, and the contract has a firm fixed price pricing type. The contract was awarded on December 20, 2017, with a completion date of February 13, 2020. The contract is set aside for total small business participation, and the potential...
- The Defense Health Agency awarded a $1.3 million Phase II Small Business Innovation Research (SBIR) contract to Safetraces, Inc. on September 15, 2025, for the development of field-deployable environmental biosensing technology to support military readiness through rapid pathogen intelligence. The contract, designated as a total small business set-aside with firm fixed pricing, is scheduled for completion by January 14, 2028, and will be performed at the awardee's facility in Pleasanton,...
- <p>This federal contract award W81XWH15C0163 was issued by the U.S. Army Medical Command (MEDCOM) to Dxdiscovery Inc., a small business concern, under the Small Business Innovation Research (SBIR) program. The $149,714.90 firm-fixed-price contract is for Phase I of an SBIR project with a completion date of April 28, 2016. The contract is a definitive contract and has a total small business set-aside designation.</p>
- The Defense Health Agency awarded a $1.3 million Small Business Innovation Research (SBIR) Phase II contract to Tao Treasures, LLC, doing business as Nanobiofab, on September 5, 2025. The contract, designated as a Total Small Business set-aside, supports development of Rapid-INOSE, a next-generation intelligent diagnostic platform designed to enable precision infection management through broad-spectrum volatile organic compound (VOC) sensing and artificial intelligence. The work is scheduled for...